Infectious Disease & Vaccines
| 4 min read
A multicountry study shows that a point-of-care TB test performs comparably to established molecular diagnostics while offering a simpler workflow and faster turnaround.
| 4 min read
New vaccines, monoclonal antibodies, and oral therapies offer hope against the growing threat of tick-borne infections.
| 5 min read
ReiThera’s gorilla-derived adenovirus vector is helping advance vaccines and therapies for COVID-19, HIV, Ebola, and even cancer.
| 5 min read
Pharma deals, newborn screening programs, FDA approvals, and more led the news this week.
| 2 min read
Multi-year US government award will support rapid, cost-effective production of filovirus antibody therapies for outbreak response.
| 4 min read
A new system lets researchers build and reprogram phage genomes from digital sequence data, potentially enabling scalable, customizable therapies for drug-resistant bacteria.
| 5 min read
While faster reviews could bring life-saving treatments to patients sooner, compressed timelines could also limit regulatory scrutiny and strain FDA resources.
| 2 min read
The approach pairs ultrasound-induced tumor cell death with real-time antigen capture to drive both local and systemic immune responses.
| 4 min read
Billion-dollar partnerships, Phase 1 wins, AI regulatory tools, and more led the news this week.
| 4 min read
FDA updates, pharma tariff agreements, gene editing deals, and more led the news this week.
| 4 min read
New vaccines and antiviral injections that could offer significantly better and broader protection against the flu are now in clinical trials.
| 6 min read
A century after the first vaccine, tuberculosis still claims over a million lives a year, but promising research could change the story.
